ACTIP (the Animal Cell Technology Industrial Platform) is an informal science-based forum of European companies employing animal cell technology in the development and production of biopharmaceuticals, vaccines and other preventative or therapeutic approaches (www.actip.org). Twice a year the ACTIP member company representatives, invited speakers and observer companies meet to discuss scientific research, development, technology and regulatory topics of mutual interest. The meetings take place in the hometowns of member companies (and sometimes on the premises) and are characterized by a friendly, open atmosphere that allows good interactions, networking and scientific discussions.
ACTIP opens up these informal industrial meetings to young scientists working on a project in biomanufacturing or related activity of industrial interest, i.e. development of new expression systems, new mammalian cell lines, cell culture processes, test development. The project might have been conducted in industry, academia or a government agency.
For this purpose, ACTIP publishes regular Calls for Application for an ACTIP Fellowship. The last call for applications has been published in spring 2019.
Open Call for ACTIP Fellowships Applications 2019-2020
The ACTIP Fellowship consists of all costs paid to attend a two-day ACTIP meeting. In order to be selected for such an opportunity, ACTIP invites young scientists to send in an application.
How to apply
Applicants should be younger than 40 years of age, educated to at least degree level in one of the disciplines underlying biomanufacturing, and based in Europe. The applicant should describe his/her involvement in a recent project on biomanufacturing or related activity of industrial relevance. Project descriptions should not exceed one A4 page. The application should be accompanied by a recent Curriculum Vitae with full contact details. Both the project description and recent CV should be sent to: Dr. Erwin van Vliet, Executive Secretary ACTIP, email: firstname.lastname@example.org
Applications can be sent from 27 May until 9 August 2019 (24:00 CET). Evaluations by ACTIP experts will take place from 10 August to 30 September 2019. Selected fellows will be notified by 15 October 2019. The shortlist of selected fellows will be published on the ACTIP website. The meetings to which the selected ACTIP fellows shall be invited will take place during the period from November 2019 to June 2021.
For more information on the last call for application download the flyer here.
“It was an excellent experience participating in this event as it generated great networking opportunities and it allowed for presenting research projects in front of representatives from key biopharmaceutical companies working with animal cells.”
“It was a great pleasure to be part of the conference about topical subjects in animal cell technologies of biopharmaceutical companies and to present my research work to that expert audience.”
“The best opportunity to network with leaders from different companies in a family atmosphere, discuss about recent topics in the field of animal cell technology and get an insight in companies.”
“I am greatful for the pleasant experience to meet and discuss with innovative thinkers from many stakeholder companies in biopharma. The networking atmosphere was greatly intensified by an intimate atmosphere and joyful social program.”
Sara Pereira (ACTIP Fellow 2017-2018)
Alina Handl (ACTIP Fellow 2017-2018)
Michael Sokolov (ACTIP Fellow 2017-2018)
Since its inception in 2009, 33 Fellows have been awarded with the ACTIP Fellowship.
The last Fellow was given the ACTIP Fellowship Award in Nijmegen, The Netherlands on 16 May 2019.
All Fellows that received their honours at the ACTIP meetings since 2009 are shown below with the title of their projects:
Winners fellowship 2017-2018
Alina Handl (awarded in June 2018)
Development of M3C Strategies in Production Processes with CHO Cell Cultures to Prevent the Formation Product Aggregation during Process
Biberach University of Applied Sciences & Ulm University, Germany
Winners fellowship 2015-2016
Gonçalo M.C. Rodrigues (awarded in May 2017)
Large-Scale Production of Human Oligodendrocyte Precursor Cells from Pluripotent Stem Cells
University of Lisbon & University of California, Portugal
Lisa A. Pieper (awarded in May 2016)
Engineering of recombinant antibody producing CHO cells to improve productivity and robustness by knockdown/knockout strategies
University of Stuttgart, Germany
Winners fellowship 2013-2014
2D fluorescence spectroscopy in combination with extrinsic fluorescence dyes as powerful tool during process development to ensure product quality
University of Biberach, Germany
Winners fellowship 2012
Analysis of the key intracellular signalling pathways involved in the suspension and serum-free adaptation of CHO cells
University of Sheffield, United Kingdom
Winners fellowship 2011
The engineering design paradigm as a tool to enhance industrial recombinant monoclonal antibody production
Lonza Biologics, United Kingdom
mHost-XS – A new versatile donor- & expression vector for protein production in eukaryotic systems
Helmholtz Centre for Infection Research, Germany
Application of metabolomics technologies for the evaluation of data driven bioprocess control in CHO cell cultures
Boehringer Ingelheim, Germany
Applying enhanced Quality by Design approach for the design space of a mammalian cell culture process
Merck Serono, Switzerland
Winners fellowship 2010
Multi-frequency permittivity measurements for real time monitoring supervision and control of cell culture processes
National Research Council Canada, Biotechnology Research Institute, Canada
Rutger van Wielink
Improving the production of deINS1 influenza virus in animal cell culture
Wageningen University, Central Veterinary Institute, The Netherlands
Winners fellowship 2009
Engineering mammalian cells for enhanced recombinant protein production
Dept. of Biosciences, University of Kent, United Kingdom
Systems Biotechnology Approaches in Industrial Mammalian Cell Culture
Boehringer Ingelheim Pharma GmbH & Co. KG
A BP Process Science, Germany
High performance minicircle for industrial production of recombinant therapeutic agents
Helmholtz Center for Infection Research, Germany
Biological relevant cell systems: the conditional immortalization system
Helmholtz Center for Infection Research, Germany